A lethal mouse #model of #Oz virus #infection reveals hepatic involvement and enables evaluation of #antiviral and #vaccine efficacy
Abstract
Oz virus (OZV), a member of the genus Thogotovirus in the family Orthomyxoviridae, is an emerging tick-borne virus reported in Japan. A fatal human case and seroepidemiological evidence of widespread exposure among wild animals and humans suggest its potential public health significance. However, no animal models suitable for pathogenic studies or evaluation of countermeasures are available for OZV. Here, we have established a lethal mouse model of OZV infection using cell-adapted virus and mice lacking type I interferon signaling (B6 Ifnar1 KO mice). OZV infection resulted in 100% mortality and was characterized by robust viral replication in the liver and spleen, severe hepatitis, and acute liver injury. Using this model, we also demonstrated that oral administration of T-705, an antiviral drug widely used against RNA viruses, as well as immunization with an inactivated whole virus particle vaccine, protected B6 Ifnar1 KO mice from lethal OZV infection by mitigating the acute hepatitis. The present study provides critical insights into OZV pathogenesis and establishes a practical in vivo platform for the development of countermeasures against OZV infection.
Competing Interest Statement
The authors have declared no competing interest.
Funder Information Declared
Japan Society for the Promotion of Science, 25K18810, 25K09431
Japan Agency for Medical Research and Development, JP223fa627005, JP24wm0225044
Source:
Link: https://www.biorxiv.org/content/10.64898/2026.01.29.702403v1
____

Comments
Post a Comment